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The surface protein (GP) of Marburg virus (MBG) is synthesized as a 90-kDa precursor protein which is cotranslationally
modified by the addition of high-mannose sugars (140 kDa). This step is followed by the conversion of the N-linked sugars
to endoglycosidase H (endo H)-resistant species and the addition of O-linked oligosaccharides leading to a mature protein
of 170–200 kDa approximately 30 min after pulse labeling. The mature form of GP is efficiently transported to the plasma
membrane. GP synthesized using the T7 polymerase-driven vaccinia virus expression system was transported with essen-
tially the same kinetics as the authentic GP. However, the protein that is shown to appear 30 min after pulse labeling at
the plasma membrane was slightly smaller (160 kDa) than GP incorporated into the virions (170 kDa). Using a recombinant
baculovirus, GP was expressed at high levels in insect cells. Three different species could be identified: a 90-kDa unglycosyl-
ated GP localized in the cytoplasm and two 140-kDa glycosylated proteins. Characterization of the glycosylated GPs revealed
that processing of the oligosaccharides of GP was less efficient in insect cells than in mammalian cells. The majority of
GP remained endo H sensitive containing high-mannose type N-linked glycans, whereas only a small fraction became endo
H resistant carrying processed N-glycans and O-glycans. Tunicamycin treatment of the GP-expressing cells demonstrated
that N-glycosylation is essential for the transport of the MBG surface protein. q 1996 Academic Press, Inc.
INTRODUCTION surface protein is only expressed after mRNA editing,
MBG GP is encoded by a single ORF (Volchkov et al.,
Marburg virus (MBG) and the closely related Ebola 1996; Sanchez et al., 1996). Two hydrophobic regions
virus (EBO) make up the family of Filoviridae, which to- have been identified in GP, one at the N-terminus, the
gether with the Paramyxoviridae and Rhabdoviridae con- other in the C-terminal region. Amino acid sequencing
stitutes the order Mononegavirales. Filoviruses are revealed that the N-terminal hydrophobic region is not
highly pathogenic for humans and nonhuman primates present in the mature protein, indicating that this region
causing a severe hemorrhagic fever with fatality rates of serves as signal peptide, which is cleaved in the ER
30% for MBG and up to 90% in the case of EBO (for (Will et al., 1993). The C-terminal hydrophobic domain is
reviews see Martini and Siegert, 1971; Pattyn, 1978). The probably used as membrane anchor, and the last 8 amino
natural reservoir of filoviruses is still unidentified. The acids constitute the cytoplasmic tail. Two fatty acid at-
prototype of the filoviruses, MBG, was isolated in 1967 tachment sites were identified at the boundary between
when several laboratory workers were infected after con- membrane anchor and cytoplasmic domain (Funke et al.,
tact with imported monkeys (Martini and Siegert, 1971). 1995). The sequence of GP contains 19 potential N-linked
MBG virions are bacillus-shaped particles (average glycosylation sites and several clusters of hydroxyamino
length 680 nm, 80 nm diameter) containing seven struc- acids which can serve as O-linked glycosylation sites
tural proteins. Four of these are the protein components (Will et al., 1993). Oligosaccharide analysis revealed that
of the nucleocapsid: the nucleoprotein (NP, Sanchez et the sugar side chains account for approximately 50% of
al., 1992), the L protein (Mu¨hlberger et al., 1992), and the the molecular weight. Most of the N-linked sugars belong
viral proteins VP35 and VP30. In analogy to the closely to the complex type oligosaccharides. Furthermore, GP
related EBO, VP40 and VP24 may be matrix proteins (El- contains a substantial number of O-linked oligosaccha-
liott et al., 1985). The envelope of the virus is decorated rides, which make up the main part (55 mol%) of the
by the only surface protein, GP (Mr 170 kDa), which is sugar moiety (Geyer et al., 1992). O-glycosylation is re-
inserted into the viral membrane as a homotrimer (Feld- ported only from one other viral glycoprotein of the order
mann et al., 1991). The GP gene is 2844 nucleotides in Mononegavirales, the respiratory syncytial virus G pro-
length and encodes a protein of 681 amino acids (Will et tein (Gruber and Levine, 1985). Another interesting fea-
al., 1993). In contrast to EBO, where the virion-associated ture of GP is the unusual structure of its oligosaccha-
rides, which completely lacked terminal sialic acids
when MBG was grown in E6 cells (Geyer et al., 1992).1 To whom correspondence and reprint requests should be ad-
dressed. E-mail: Becker@mailer.uni-marburg.de. Since GP is the only membrane protein of MBG, it is
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assumed to be responsible for virus entry into host cells of the recombinant baculovirus (designated vVL-GP)
were described by Funke et al. (1995).(Becker et al., 1995) and to be the major target for the
immune response of the infected organism. Will et al.
Vaccinia virus transfection system(1993) and Bukreyev et al. (1993) reported that the C-
terminal part of GP contains a region that shows a high HeLa cells (2.5 1 106) were infected with vTF7-3 at an
degree of homology to a presumptive immunosuppres- m.o.i. of 5 PFU per cell. One hour p.i. cells were trans-
sive domain observed in some retroviruses. Whether the fected with 5 mg pTM-GP and/or pGem-NP (Sanchez et
failure to detect neutralizing antibodies against MBG can al., 1992) using the lipofectin (Gibco BRL) precipitation
be explained by the presence of this domain remains to technique (Felgner et al., 1987). At 4–6 hr after transfec-
be seen. tion cells were used for metabolic labeling or immunoflu-
So far, analysis of GP has mainly been done on virion- orescence analyses.
associated protein. In this study we have analyzed intra-
cellular transport and processing of GP in MBG-infected Pulse–chase experiments
E6 cells and by using vaccinia virus and baculovirus
Experiments were done with 2.5 1 106 E6 cells in-expression systems.
fected with MBG or 2.5 1 106 HeLa cells infected with
vTF7-3 and transfected with pTM-GP. Five-day-p.i.MATERIALS AND METHODS
MBG-infected cells or 5- to 6-hr-p.i. vaccinia virus-in-
Viruses and cell lines fected cells were starved for 1 hr with methionine- and
cystein-deficient Dulbecco’s medium and thereafter la-The Musoke strain of MBG isolated 1980 in Kenya
beled with 100 mCi [35S]Promix (Amersham Buchler) for(Smith et al., 1982) was grown in E6 cells, a cloned cell
20 min. Postlabeling chases were in the presence ofline of Vero cells (ATCC CRL 1586). vTF7-3 (Fuerst et al.,
methionine- and cystein-containing Dulbecco’s me-1986) and the strain WR of vaccinia virus were propa-
dium. After different incubation periods medium wasgated in HeLa cells. Autographa californica nuclear poly-
removed, and cells were washed with ice-cold PBShedrosis virus (AcMNPV) and vVL-GP (see below) were
and lysed with RIPA buffer (20 mM 2-(N-morpholino)-grown in a Spodoptera frugiperda cell line (Sf9).
ethanesulfonic acid (MES), 55 mM Tris, 200 mM NaCl,
10 mM EDTA, 1% (v/v) SDS (pH 7.8), 1% (v/v) Triton X-Propagation of viruses and protein labeling
100, 5% (v/v) Trasylol (Bayer), 1 mM phenylmethylsulfo-
MBG, the recombinant vaccinia viruses, and the re- nyl fluoride (PMSF), 10 mM iodoacetamide). Cell ly-
combinant baculovirus were propagated as described sates were subsequently sonicated and incubated for
previously (Funke et al., 1995; Becker et al., 1994). Label- 1 hr at 47 with a rabbit preimmune serum followed
ing of MBG virions was done as follows: Cells were by 1 hr incubation with protein A – Sepharose (Sigma).
infected at a multiplicity of infection (m.o.i.) of 1002 PFU Immune complexes were precipitated at 14,000 rpm at
per cell (Mu¨hlberger et al., 1992). Five days post infection 47 for 15 min in a tabletop centrifuge, and supernatants
(p.i.) medium was removed and cells were incubated for were further incubated overnight at 47 with a 1:100
16 hr with 20 mCi [35S]methionine (Amersham Buchler) dilution (final concentration) of an anti-GP rabbit serum
per milliliter of medium. Harvesting of radiolabeled viri- in RIPA buffer (kindly provided by H. Feldmann). Com-
ons was performed as described by Funke et al. (1995). plexes of GP and antibody were incubated for 1 hr with
30 ml protein A – Sepharose and centrifuged at 14,000
Molecular cloning and construction of recombinant rpm for 15 min. Pellets were washed three times with
viruses RIPA buffer, resuspended in sample buffer (20% glyc-
erin, 6% SDS, 375 mM Tris – HCl, pH 6.8, 10% mercapto-The vaccinia virus-specific plasmid pTM1 (Fuerst et
ethanol, 2.5% saturated bromphenol blue solution),al., 1986) was kindly provided by B. Moss. All methods for
heated for 5 min to 957, and subjected to SDS – PAGEcloning, transformation of bacteria (XL1Blue, Stratagene,
and fluorography.and TG1) were carried out according to Sambrook et al.
(1989). For cloning of the GP gene in different vectors a
Surface immunoprecipitation
recombinant pGEM3Zf(/) plasmid containing the ORF of
the gene was used (Will et al., 1993). The recombinant Experiments were carried out essentially as described
under pulse–chase experiments. The radioactive pulseplasmid was cut with SalI for cloning the gene into the
SalI site of the vector pTM1. The sequence of the cloned was for 30 min. After different incubation periods the
medium was removed, and cells were rinsed three timesinsert was verified by DNA sequencing over the entire
length. The recombinant pTM1 plasmid (pTM-GP) was with ice-cold PBS supplemented with 1 mM CaCl2 and
0.5 mM MgCl2 (PBS
2/) and thereafter incubated with 1used for expression of GP with the vaccinia virus T7
system (Fuerst et al., 1986). Cloning of the GP gene into ml of a 1:66 dilution of the anti-GP rabbit serum in PBS2/
for 1 hr at 07. Unbound antibody was removed by washingthe baculovirus-specific vector pVL1392 and construction
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three times with ice-cold PBS, and cells were lysed there- linked a(1-3), a(1-6), or a(1-2) to mannose; and Datura
stramonium agglutinin (DSA), which binds galactose b(1-after with 1 ml RIPA buffer. Then lysates were incubated
for 2 hr with 50 ml protein A–Sepharose, immune com- 4) glucosamine in glycans of the complex or hybrid type.
Lectin precipitation. Baculovirus-infected Sf9 cells (1plexes were spun down, and pellets were stored at0207.
To precipitate intracellular GP the supernatant was incu- 1 106) were washed twice with PBS, resuspended in 750
ml RIPA buffer, and sonicated. After removal of cell debrisbated for 1 hr at 47 with 15 ml of the anti-GP antibody for
precipitating, followed by a 2-hr incubation with protein (13,000 rpm, 10 min, 47) supernatants were incubated
overnight at 47 with 50 ml of agarose-coupled GNAA–Sepharose. Immune complexes were further treated
as described above and finally loaded onto SDS–PAGE (Sigma). Lectin-bound proteins were precipitated at
13,000 rpm for 15 min at 47 and washed 31 with RIPA.and detected by fluorography.
The final pellets were resuspended in 20 ml denaturing
Fluorography buffer (see glycosidase treatment) and boiled for 10 min
at 957. Samples were split into 2 fractions; one was di-Radiolabeled proteins were separated on 10% SDS
gested with endoglycosidase H (endo H) as described,slab gels as described by Laemmli (1970). Thereafter,
and the other was left untreated. Samples were sepa-the gels were fixed in 10% acetic acid, 30% ethanol for
rated by SDS–PAGE, blotted onto PVDF membranes, and15 min, incubated in Enlightning (Dupont) for another 20
probed with a monoclonal antibody against GP.min, dried, and subjected to fluorography.
Indirect immunofluorescence analysis
Immunoblot analysis
Vaccinia virus expression system. Monolayers of 5 1
At 36 hr p.i. 1 1 106 baculovirus-infected Sf9 cells 105 HeLa cells grown on glass coverslips (7 cm2) were
(m.o.i. of 10 PFU per cell) were washed twice with PBS, infected with vTF7-3 at an m.o.i. of 10 PFU/cell and trans-
resuspended in 500 ml triton lysis buffer (20 mM MES, fected with two plasmids expressing GP (pTM-GP) and
55 mM Tris–HCl (pH 7.8), 200 mM NaCl, 10 mM EDTA, NP (pGem-NP; Sanchez et al., 1992) as described above.
1% (v/v) Triton X-100, 5% (v/v) Trasylol, 1 mM PMSF, 10 Six hours after transfection the monolayer was rinsed
mM iodoacetamide), and proteins were separated by twice with PBS. For surface staining the cells were
10% SDS–PAGE (10 ml per lane). After electrophoresis shifted to 47 and incubated with a mixture of a mono-
proteins were blotted onto PVDF membranes (Millipore, clonal antibody against GP (diluted 1:2 in PBS/3% BSA)
P-15552) by semidry blot technique. The membranes and a guinea pig anti-NP antiserum (diluted 1:60 in PBS/
were blocked with 10% milk powder in PBS at 47 over- 3% BSA; Becker et al., 1994) for 1 hr at 47. Then cells
night, incubated for 1 hr with the first antibody [either a were washed twice with ice-cold PBS and fixed with 3%
monoclonal antibody raised against GP, diluted 1:30 in paraformaldehyde in PBS for 15 min at RT. Subsequently
PBS/0.1% Tween 20 (PBS/T), supplemented with 1% milk cells were incubated in 100 mM glycine for 10 min at RT
powder or a guinea pig anti-MBG antiserum, diluted and then probed for 1 hr with a mixture of a Cy3-conju-
1:500], washed three times with PBS/T, and subsequently gated sheep anti-mouse antiserum (Sigma) and a FITC-
incubated for 1 hr with either an anti-mouse IgG antise- conjugated rabbit anti-guinea pig antiserum (Dako). Both
rum or an anti-guinea pig IgG antiserum coupled to sera were diluted 1:100 in PBS/3% BSA. Finally, cells
horseradish peroxidase (Dako) diluted 1:5000 (for ECL) were washed and analyzed by immunofluorescence. For
or 1:500 (colorimetrically) in PBS/T supplemented with intracellular staining cells were permeabilized by incu-
1% milk powder. After the second incubation, blots were bating with a mixture of acetone:methanol 1:1 at 0207
washed two times with PBS/T and twice with PBS, and for 5 min. Subsequently cells were washed twice with
thereafter bound antibodies were detected either colori- PBS and the remaining acetone was neutralized by 100
metrically or with ECL (Amersham Buchler). mM glycine for 10 min at RT. Thereafter, cells were
washed once with PBS and incubated with a mixture of
Lectin analysis
a monoclonal antibody against GP (diluted 1:2 in PBS/
3% BSA) and a guinea pig anti-NP antiserum (diluted 1:60Lectin blot. Baculovirus-infected Sf9 cells were lysed
as described above, and cell lysates were separated by in PBS/3% BSA) 1 hr at RT. After the cells were washed
31 with PBS, samples were incubated with the second10% SDS–PAGE. Thereafter, proteins were blotted onto
a PVDF membrane that was blocked with a blocking antisera as described above.
MBG. E6 cells (5 1 105) were grown on glass cov-reagent supplied with the Glycan Differentiation kit,
(Boehringer Mannheim). Further procedures followed the erslips (7 cm2), infected with MBG, and processed 3 days
p.i. as described above for vaccinia virus.supplier’s prescription. The following lectins were used:
Arachis hypogaea agglutinin (PNA), which specifically
Glycosidase treatmentbinds unsubstituted galactose b(1-3) N-acetylgalactos-
amine cores of O-glycans; Galanthus nivalis agglutinin Vaccinia virus expression system, MBG. The last pellet
of the immunoprecipitation analysis was boiled for 5 min(GNA), which recognizes terminal mannosyl residues
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in 20 ml of a denaturing buffer (0.2% SDS, 1% octylgluco- at 47 for 30 min. The pellets were washed twice with 750
ml 70% ethanol, dried, and resuspended in 100 ml sampleside, 1% mercaptoethanol). The samples were then cen-
trifuged for 5 min at 14,000 rpm and supernatants were buffer. Samples (10 ml) were loaded onto a 10% SDS–
PAGE and blotted onto PVDF membranes. Membranesdivided into two fractions. Both were supplied with 10 ml
of acetate buffer (100 mM sodium acetate (pH 7.0), 10 were analyzed by the immunoblot technique with the
described anti-GP monoclonal antibody.mM EDTA), and to one of the fractions 1 ml endo H
(1 mU; Boehringer Mannheim) was added. Glycosidase
cleavage proceeded overnight at 377. Thereafter samples
RESULTS
were mixed with an equal volume of sample buffer and
loaded onto a 10% SDS– PAG. After electrophoresis gels Intracellular transport of the MBG-GP in vertebrate
were subjected to fluorography. cells
Baculovirus expression system. At 36 hr p.i. 1 1 106
E6 cells were infected with MBG and labeled 5 daysvVL-GP-infected Sf9 cells (m.o.i. of 10 PFU per cell) were
p.i. for 20 min with [35S]Promix followed by chase incuba-washed twice with PBS/5 mM PMSF and spun down.
tions of 10 to 240 min. At the indicated time cells wereAfter resuspending the cell pellet in 200 ml denaturing
lysed, and GP was immunoprecipitated with a rabbit anti-buffer (see above), cell lysates were divided into 22.5-ml
GP antiserum. Immediately after the pulse a GP-specificaliquots and supplied with 22.5 ml of acetate buffer/5 mM
140-kDa polypeptide band could be detected (Fig. 1A;PMSF. Proteins were then digested with 4 ml of different
arrowhead). After 30 min another protein band occurred,glycosidases: Endo H (1 mU/ml), N-glycosidase F
with a molecular weight of 170–200 kDa corresponding(PNGase F, 50 mU/ml), or endo-a-N-acetylgalactosamini-
to the virion-associated protein (arrow). During the chasedase (O-glycosidase; 0.3 mU/ml; all enzymes were sup-
the 140-kDa species disappeared coincidently with theplied by Boehringer Mannheim). After the incubation pe-
appearance of the 170-kDa form. After digestion of immu-riod (377, overnight) samples were mixed with an equal
noprecipitated cell lysates with endo H the 140-kDa formvolume of sample buffer, separated by 10% SDS–PAGE,
was converted to a 90-kDa protein (Fig. 1B; arrowhead)and thereafter blotted onto PVDF membranes. The blot-
representing the unglycosylated form of GP (Will et al.,ted GP was detected with a guinea pig anti-MBG antise-
1993), whereas the 170-kDa protein was resistant. Theserum or with the lectin PNA according to the supplier.
results indicated that the 170-kDa protein is the mature
Tunicamycin treatment form of GP and the 140-kDa species is a precursor with
high-mannose oligosaccharides.
Sf9 cells (1 1 106) were infected with vVL-GP at an For further investigations GP was expressed in HeLa
m.o.i. of 10 PFU per cell. At 24 hr p.i. 10 mg tunicamycin/ cells with the vaccinia virus T7 expression system and
ml TC100 medium without FCS was added. After 10 hr pulse-labeled in the same manner as described for MBG-
the medium was changed and tunicamycin-containing infected E6 cells (Figs. 1C and 1D). As in MBG-infected
medium was added again. Three hours later, cells were cells, the high-mannose form of GP (140 kDa, see arrow-
lysed and proteins were separated by SDS–PAGE, blot- head) appeared immediately after the pulse and was
ted onto PVDF membranes, and analyzed by the lectin subsequently converted into the mature form (see arrow).
PNA or a guinea pig antiserum against MBG. In addition, a protein was detected migrating at approxi-
mately 90 kDa corresponding to the unglycosylated form
Proteinase protection assay
of GP. After endo H digestion of the high-mannose form
of GP the resulting protein comigrated with the unglyco-Sf9 cells (1 1 107) were infected with vVL-GP at an
sylated form (Fig. 1D, arrowhead). The estimated t12 form.o.i of 10 PFU per cell. At 36 hr p.i. cells were washed
three times with PBS, incubated for 5 min on ice, scraped gaining endo H resistance was approximately the same
as that detected in MBG-infected cells (90 min). The ma-into 25 ml PBS, and pelleted at 1500 rpm for 5 min. The
pellet was resuspended in 1 vol of hypotonic buffer (10 ture form (arrow) of the vaccinia virus-expressed GP was
smaller (160 kDa) than the authentic GP (170 kDa). How-mM Tris–HCl, pH 7.4, 10 mM KCl, 1.5 mM MgCl2 , 10 mM
CaCl2) and allowed to stand on ice for 2 hr. Thereafter, the ever, the unglycosylated species (90 kDa, arrowheads in
Figs. 1B and 1D) of both GPs and the endo H-sensitiveswollen cells were sonicated 30 times and immediately
centrifuged at 45,000 rpm at 47 for 30 min. The superna- form had exactly the same size (140 kDa, arrowheads in
Figs. 1A and 1C), indicating that the difference in size istant was saved, and the pellet resuspended in 500 ml of
the hypotonic buffer. Aliquots of the pellet (50 ml) and the probably caused by an altered glycosylation pattern in
the late Golgi apparatus or the trans Golgi network (TGN).supernatant were incubated for 30 min on ice with 0.5
mg proteinase K (Serva) in the presence or the absence Indirect immunofluorescence analyses were carried
out to analyze whether GP is presented at the cell sur-of 1% Triton X-100. Then 16 ml of 50 mM PMSF and 70
ml of 25% trichloric acid were added and samples were face. MBG-infected E6 cells were reacted with a mono-
clonal anti-GP antibody and a guinea pig anti-NP antise-incubated at 47 for 30 min before they were centrifuged
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ization. The same immunofluorescence experiments
were performed with recombinant GP expressed with the
vaccinia virus T7 expression system. In Figs. 2E–2H,
HeLa cells were infected with vTF7-3 and then doubly
transfected with plasmids encoding the GP and the NP
gene under the control of the T7 promoter. Immunofluo-
rescence data revealed that GP and NP were both ex-
pressed in the same cells (Figs. 2E and 2F), but only GP
could be detected at the surface (Figs. 2G and 2H). vTF7-
3-infected cells without transfection and mock-infected
cells demonstrated no significant staining (data not
shown). These findings suggest that the vaccinia virus-
expressed GP, like the authentic GP, is transported to
the plasma membrane. The time course of surface pre-
sentation of GP is shown in Fig. 3. HeLa cells infected
with vTF7-3 and transfected with a recombinant pTM1
plasmid encoding GP (pTM-GP) were subjected to
pulse–chase labeling. GP localized at the surface was
identified by incubation of intact cells with anti-GP anti-
body for 1 hr at 07 and by binding of the GP–antibody
complexes to protein A–Sepharose following cell lysis.
After removal of surface-bound GP, intracellular GP was
immunoprecipitated from cell lysates. Whereas the high-
mannose form of GP was detected immediately, the intra-
cellular mature (endo H-resistant) form of GP was de-
tected only 30 min after the pulse (Fig. 3A). GP arrived
at the cell surface almost simultaneously (Fig. 3B).
Expression of GP in insect cells using a baculovirus
vector
The lepidopteran cell line Sf9 was infected with the
FIG. 1. Pulse–chase analysis of GP. (A and B) MBG-infected E6 cells recombinant baculovirus vVL-GP containing the ORF ofwere labeled with [35S]Promix for 20 min at 5 days p.i. and then chased
the GP gene of MBG. At 36 hr p.i. cells were harvested,for various times as indicated. Labeled proteins were immunoprecipi-
and expression of GP was detected by Coomassie bluetated using a guinea pig anti-GP antiserum. Samples were analyzed
by SDS–PAGE followed by fluorography. (A) Untreated proteins. Indi- staining (Fig. 4A) and by Western blot analysis using
cated by an arrow is the mature form of GP; the arrowhead marks the a monoclonal antibody against GP (Fig. 4B). GP was
endo H-sensitive form of GP. (B) Proteins digested with endo H. Arrow expressed in two forms in Sf9 cells: a 140-kDa (blackmarks the mature form of GP; arrowhead marks the unglycosylated
arrow) and a 90-kDa species (arrowhead). Western blotform of GP. (C and D) vTF7-3-infected HeLa cells were labeled with
analysis revealed that the two species were present in[35S]Promix for 20 min at 6 hr p.i. and then chased for various times
as indicated. Labeled proteins were immunoprecipitated using a almost equal amounts, whereas in the Coomassie blue-
guinea pig anti-GP antiserum. Samples were analyzed by SDS–PAGE stained gel the 140-kDa form was underrepresented.
followed by fluorography. (C) Untreated proteins. Indicated by an arrow Since glycosylated proteins are known to be poorlyis the mature form of GP; the arrowhead marks the endo H-sensitive
stained by Coomassie blue, these observations suggestform of GP. (D) Proteins digested with endo H. The arrow marks the
that the 140-kDa GP might represent the glycosylatedmature form of GP, the arrowhead the unglycosylated form of GP.
and the 90-kDa GP the nonglycosylated protein. This
view is supported by the findings that the unglycosylated
in vitro translation product of GP gene is a 90-kDa proteinrum under native conditions (before fixing, without per-
meabilization, at 47). For control, infected cells were (Will et al., 1993) and that only the 140-kDa form reacts
with lectins (see below). Large quantities of GP werepermeabilized by acetone treatment and stained with the
same antibodies. Staining of NP, which is located strictly synthesized in insect cells, which, in contrast to the vac-
cinia virus system, could even be detected by Coomassieintracellularly, serves to indicate the integrity of the
plasma membrane. As can be seen in Fig. 2 both NP blue staining. Serial dilutions of cell lysates analyzed by
Western blot revealed that the amount of GP expressedand GP gave a signal in permeabilized cells (Figs. 2A
and 2B), whereas under native conditions only GP could with the baculovirus system exceeds the amount of vac-
cinia virus-expressed GP by approximately 300 times (notbe detected (Figs. 2C and 2D), reflecting its surface local-
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FIG. 4. Expression of GP in insect cells. Sf9 cells were infected with
vVL-GP or AcMNPV (wt) or not infected (mock). At 36 hr p.i. cells were
lysed, and proteins were separated by SDS–PAGE. (A) Coomassie
blue staining. (B) Western blot probed with a monoclonal antibody
against GP. The position of MBG GP is marked by an dashed arrow,
the position of the glycosylated GP expressed in Sf9 cells by an black
arrow, and the position of the unglycosylated form of GP expressed in
Sf9 cells by an arrowhead. MBG, MBG structural proteins.
remained in the pellet. In the presence of Triton X-100,
the 90-kDa protein was digested by proteinase K in the
pellet fraction as well as in the supernatant. GlycosylatedFIG. 3. Surface immunoprecipitation of GP in HeLa cells. HeLa cells
were infected with vTF7-3 and subsequently transfected with pTM-GP. GP, however, was protected. This experiment shows that,
Cells were labeled with [35S]Promix for 30 min at 6 hr p.i. and then unlike glycosylated GP, the nonglycosylated form is not
chased for various times as indicated. Labeled proteins were immuno- translocated into the ER.
precipitated using a guinea pig anti-GP antiserum. Samples were ana-
GP expressed in Sf9 cells is significantly smaller thanlyzed by SDS–PAGE followed by fluorography. (A) Intracellular GP.
the authentic GP present in virions (Fig. 4, dashed arrow)Indicated by an arrow is the mature form of GP, the arrowhead marks
the endo H-sensitive form of GP. The band migrating at 90 kDa repre- reflecting different glycosylation pathways in insect and
sented a nonglycosylated form of GP. (B) Surface GP. The arrow marks mammalian cells. To further analyze carbohydrate pro-
the mature form of GP. cessing of GP in insect cells, vVL-GP-infected Sf9 cells
were lysed 36 hr p.i., and cell lysates were digested with
different glycosidases followed by Western blot analysisshown). The 90-kDa form of GP could only be detected in
and detection with a guinea pig anti-MBG antiserum orinsect cells, where the expression level was significantly
with different lectins (Fig. 6). The recombinant GP washigher than in mammalian cells. Thus, it was of interest
recognized by PNA (specific for the core unit of O-gly-to find out whether the occurrence of nonglycosylated
cans; Fig. 6B) and GNA (specific for high-mannose typeGP was due to exhausted glycosylation machinery or to
oligosaccharides; Fig. 6C), suggesting that the proteininsufficient translocation into the ER. In the first case, the
contained O-linked oligosaccharides and high-mannosenonglycosylated GP would be translocated into the ER
type N-glycans. DSA, which recognizes oligosaccharideswithout further processing by glycosyltransferases. In the
of the complex type and is known to detect the authenticsecond case, GP would be localized in the cytosol. To
GP (Feldmann et al., 1991), failed to bind to GP expresseddiscriminate between these possibilities, a proteinase
in insect cells (data not shown). After treatment with endoprotection assay in combination with a solubility analysis
H, which cleaves high-mannose type glycans, GP de-was performed on lysates of the vVL-GP-infected Sf9
tected by the specific antibody migrated at approximatelycells. Incubation with proteinase K in the presence or
90 kDa, whereas treatment with PNGase F led to a 93-the absence of Triton X-100 was used to discriminate
kDa product (Fig. 6A; GP is marked by arrowheads).between cytosolic and ER-sequestered proteins (Fig. 5).
Since PNGase F removes all N-glycans and endo H onlyAfter centrifugation of cell lysates, only the nonglycosyl-
high-mannose type N-glycans, it was surprising that theated form of GP was found in the supernatant. The glyco-
sylated form and a small fraction of the 90-kDa form endo H-digested GP was smaller than that treated with
FIG. 2. Surface transport of GP. E6 cells were infected with MBG or HeLa cells were infected with vTF7-3 and subsequently transfected with
pTM-GP and pGem-NP. Cells were stained with a monoclonal anti-GP antibody and with a guinea pig anti-NP serum. Bound antibody was detected
with a rabbit anti-mouse IgG coupled to Cy3 and a rabbit anti-guinea pig IgG coupled to FITC. A, C, E, and G show the Cy3-emitted fluorescence
(GP-specific signal), and B, D, F, and H show the FITC-emitted fluorescence (NP-specific signal). (A and B) MBG-infected E6 cells, permeabilized;
(C and D) MBG-infected E6 cells, surface; (E and F) vTF7-3-infected HeLa cells, transfected with pTM-GP and pGem-NP, permeabilized; (G and H)
vTF7-3-infected HeLa cells, transfected with pTM-GP and pGem-NP, surface.
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FIG. 5. Proteinase protection assay of GP expressed in Sf9 cells. Sf9 cells were infected with vVL-GP and harvested 36 hr p.i. After incubation
in a hypotonic buffer cells were sonicated and centrifuged. Pellet and supernatant were separated and treated with proteinase K in the presence
or the absence of Triton X-100. The unglycosylated GP is marked by an asterisk.
PNGase F. One possible explanation for this phenome- the untreated protein (Fig. 6A). The smaller protein bands
(90 kDa) stained by the antiserum were GP-specificnon is that PNGase F is more sensitive to sterical hin-
drance than endo H (Long et al., 1991). The O-glycosi- and might represent degradation products due to intra-
cellular proteases. When the endo H-digested cell ly-dase-cleaved GP had approximately the same size as
sates were probed with PNA, the lectin recognized a
protein, which was only slightly smaller than the undi-
gested GP (GP is marked by arrowheads, Fig. 6B).
PNGase F treatment resulted in a pronounced shift of
the PNA-detected GP to 93 kDa. Cleavage of O-linked
oligosaccharides with O-glycosidase did not change the
size of the PNA-detected protein, but diminished the sig-
nal strength (Fig. 6B). Interestingly, PNA did not stain the
above-mentioned degradation products, suggesting that
the fragments recognized by the GP-specific antibody
were due to degradation of unglycosylated or high-man-
nose type glycosylated GP. A cellular glycoprotein, which
was also recognized by PNA migrates at 200 kDa and
is shifted by PNGase F treatment to approximately 150
kDa (Fig. 6B). These experiments suggested the exis-
tence of two differently processed forms of GP: an abun-
dant endo H-sensitive fraction and a minor endo H-resis-
tant fraction, which could not be detected by the specific
antiserum, probably for quantitative reasons. This form,
however, was recognized by the more sensitive lectin
PNA. To determine the ratio between the endo H-sensi-
tive and -resistant species, GP was precipitated using
agarose-coupled GNA. Since it is known that the virion-
associated authentic GP still carries a small amount of
high-mannose type oligosaccharides (Geyer et al., 1992),
FIG. 6. Oligosaccharide analysis of GP expressed in Sf9 cells. (A
it was expected that both species of glycosylated GPand B) Sf9 cells were infected with vVL-GP (GP) or AcMNPV (wt) or
could be recognized by the lectin. GNA precipitates werenot infected (mock). At 36 hr p.i. cells were lysed and subjected to
glycosidase treatment. Digested samples were separated by SDS– digested with endo H, showing that the overwhelming
PAGE and blotted onto PVDF membranes. (A) Staining of proteins with part of glycosylated GP was endo H sensitive (Fig. 6C).
a guinea pig anti-MBG antiserum. The prominent GP band is marked However, the endo H-resistant form was also detectable.
by arrowheads. (B) Staining of proteins with the lectin PNA. GP recog-
The results of the glycosidase digestion can be summa-nized by PNA is marked by arrowheads. (C) Sf9 cells were infected
rized as follows: (i) PNGase F digestion of GP resultedwith vVL-GP (GP) or AcMNPV (wt) or not infected (mock). At 36 hr p.i.
cells were lyzed and precipitated using the agarose-coupled lectin in a 93-kDa protein recognized by the GP-specific anti-
GNA. Thereafter, samples were subjected to endo H treatment. Di- body and by PNA. (ii) After treatment with endo H, the
gested samples were separated by SDS–PAGE, blotted onto PVDF
antibody and the lectin PNA recognized two differentmembranes, and probed with a monoclonal antibody against GP. H,
protein bands: the antibody reacted with a 90-kDa pro-digestion with endo H; F, digestion with PNGase F; O, digestion with
O-glycosidase. tein, and PNA bound to a 140-kDa form. These results
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ing target cells (Becker et al., 1995) and in mediating
fusion of the viral envelope with cellular membranes. GP
is the first viral component that comes into contact with
the invaded host, and antibodies against GP should have
the potential to neutralize the infection. However, neu-
tralizing antibodies against MBG were never detected.
Also, all efforts to produce a protecting vaccine against
MBG have failed so far. It is therefore of interest that
depletory effects of MBG on the lymphatic system of
infected hosts have been reported (Ryabchikova et al.,
1994) and that a stretch of 26 amino acids has significant
homology to a immunosuppressive domain found in
some retroviruses (Will et al., 1993; Bukreyev et al., 1993).
To better understand its role as initiator of infection and
as a target and a modulator of the immune response it
is necessary to obtain detailed knowledge of the struc-
ture and maturation of GP. This includes elucidation of
the complex events involved in GP processing. Because
of the high pathogenicity of infectious virus, it is desirable
to employ vectorial expression of GP in such studies.
The potential of vector-expressed GP as a diagnostic
tool and as a vaccine is also of considerable interest.
FIG. 7. Tunicamycin treatment of GP expressed in Sf9 cells. Sf9 cells
We have therefore compared here expression and post-were infected with vVL-GP (GP) or AcMNPV (wt) or not infected (mock).
translational maturation of GP in (i) MBG-infected cells,At 24 hr p.i. tunicamycin was added and cells were harvested 13 hr
later. Cell lysates were subjected to SDS–PAGE and blotted onto PVDF (ii) HeLa cells infected with vTF7-3 and transfected with
membranes. (A) Lectin analysis with PNA. (B) Immunoblot with a guinea pTM-GP, and (iii) Sf9 cells infected with vVL-GP.
pig anti-MBG antiserum. The glycosylated form of GP is marked by an
In vertebrate cells infected with MBG, GP moleculesarrow, the unglycosylated form by an arrowhead; (/) with tunicamycin
started to gain endo H resistance (corresponding to thetreatment; (0) without tunicamycin treatment. A cellular glycoprotein,
also stained by PNA, migrates at 200 kDa. arrival in the medial Golgi compartment) 30 min after
synthesis. The t12 for Golgi transport was approximately
90 min. These data are in line with results obtained forprovide evidence that the glycosylated GP exists in vVL-
other viral glycoproteins showing that the t12 for GolgiGP-infected insect cells in at least two different forms of
localization ranges between 15 and 120 min, dependingsimilar size. One of these species, recognized by PNA
on the number of attached oligosaccharides and the sizeand resistant to endo H, represents processed GP. The
other species, which is sensitive to endo H and does of the protein (for review see Doms et al., 1993). Expres-
not bind to PNA, is the immature GP localized either sion of GP with the T7 polymerase-driven vaccinia virus
in the ER or between the ER and the medial Golgi ap- system resulted in a specific protein that was transported
paratus. with kinetics similar to authentic GP, as indicated by an
To analyze the effect of N-glycosylation on the trans- endo H resistance obtained after 45 min. GP expressed
port of GP, vVL-GP-infected Sf9 cells were treated with with the vaccinia virus system showed a different com-
tunicamycin to prevent the addition of N-linked glycans plex glycosylation pattern resulting in an apparent molec-
(Takatsuki et al., 1975). Western blot analysis of vVL- ular weight of approximately 160 kDa compared to 170
GP-infected cells revealed that GP synthesized in the kDa with authentic GP. It is reported for some other viral
presence of tunicamycin was not detected by PNA (Fig. glycoproteins that expression in the vaccinia virus sys-
7A). This observation indicates that transport of GP to tem leads to altered glycosylation (Rapp et al., 1994; Yas-
the Golgi apparatus, where O-glycosylation occurs, de- wen et al., 1993). Surface localization of GP could be
pends on N-glycosylation. Using a GP-specific antiserum detected in MBG-infected cells, suggesting that MBG
it could be demonstrated that no glycosylated form of budding occurs at the plasma membrane. This observa-
GP is present, whereas the 90-kDa unglycosylated form tion confirms the results of Schnittler et al. (1993), who
of GP seemed to be accumulated in the presence of showed by electron microscopic studies that virions
tunicamycin (Fig. 7B). were released at the plasma membrane. GP expressed
with the vaccinia virus system was also transported to
DISCUSSION the membrane, indicating that the slightly altered com-
plex glycosylation did not influence the transport compe-GP is the only surface protein of MBG (Feldmann et
al., 1991) and is suggested to play a key role in recogniz- tence of recombinant GP. In addition these experiments
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show that GP is transported to the plasma membrane (e.g., soluble interferon-g receptor, Manneberg et al.,
1994; influenza A virus hemagglutinin, Kuroda et al.,without the need of other viral proteins. First GP mole-
cules arrived at the cell surface 30 min after the radioac- 1990). It seems that insect cells process highly glycosyl-
ated proteins like MBG GP or HIV-1 gp 160 less efficientlytive pulse. After 180 min, almost all pulse-labeled GP
molecules were located at the plasma membrane, indi- than glycoproteins with only a few N-glycosylation sites,
such as the influenza A virus hemagglutinin. However,cating that, despite the unusually high glycosylation of
GP, its transport is neither very slow nor inefficient. The the addition of O-glycans to some molecules of GP indi-
cated that the protein was transported to the Golgi appa-rate-limiting step of the transport of GP is processing in
the ER and/or early Golgi compartments. Compared to ratus because O-glycosylation presumably occurs in the
cis Golgi (Wilson et al., 1993). The unglycosylated formER–Golgi transport, Golgi–plasma membrane transport
was very fast and could not be measured under the cho- of GP in insect cells was shown to be located in the
cytoplasm. Hann and Walter (1991) showed that deple-sen experimental conditions. Endo H resistance and
plasma membrane presentation occurred in our experi- tion of yeast cells from signal recognition particles (SRP)
gave rise to unglycosylated forms of naturally glycosyl-ments simultaneously. It is well established that pro-
cessing of glycoproteins in the ER and in the early Golgi ated proteins that were not translocated into the ER.
These data are in line with our observations that the(for example folding, oligomerization) are the most time-
consuming steps during the transport of viral glycopro- relation between glycosylated and nonglycosylated GP
was lowered when the overall expression level of GPteins. Later steps proceed with higher velocity (Doms et
al., 1993; Earl et al., 1991). was increased (data not shown). In this case the need
of SRP for translocation of the newly made GP into theGP could be efficiently expressed in insect cells using
the baculovirus system. It was shown that the recombi- ER exceeded the available amount, leading to nonglyco-
sylated forms of the protein.nant GP contained N- and O-linked oligosaccharides.
The expression rate was approximately 300 times higher Treatment with tunicamycin not only prevented N-gly-
cosylation of GP but also O-glycosylation (Fig. 7B), un-than that of the vaccinia virus system. Three different GP
species were detected in insect cells infected with the derlining the importance of N-glycans for the transport
of GP, as has been reported for other proteins expressedrecombinant baculovirus: (i) a mature 140-kDa form with
processed N-glycans and O-linked sugar side chains, (ii) with the baculovirus system (Tate and Blakely, 1994; Jar-
vis et al., 1990).a 140-kDa protein carrying high-mannose type N-gly-
cans, and (iii) an unglycosylated 90-kDa form. The differ- In this paper we presented data on transport and pro-
cessing of GP in MBG-infected E6 cells and of recombi-ence in size between the mature GP in insect cells and
the authentic GP is due to different glycosylation in the nant GP expressed in HeLa cells. It was shown that GP
expressed with the vaccinia virus system was trans-Golgi apparatus in insect and mammalian cells. The N-
glycans in insect cells are trimmed to trimannosyl cores ported in a similar way as the authentic GP, thus provid-
ing a tool for mutational analysis of structural and func-without further elongation, resulting in endo H-resistant
short sugar side chains (Man3GlcNAc2 or Man3(Fuc)Glc- tional features of GP and for the production of vaccines.
Using the baculovirus system GP could be expressedNAc2 ; Kuroda et al., 1990). In addition, the O-glycosidi-
cally linked oligosaccharides are also different compared in large amounts, serving as a source for large-scale
production of GP. However, glycosylation of the matureto those in mammalian cells. They consist predominantly
of the monosaccharide GalNAc and in lower amounts of protein in insect cells was considerably altered, and for
the most part oligosaccharides of GP remained in thethe disaccharide Galb1-3GalNAc (Wathen et al., 1991;
Thomsen et al., 1990). Lectin analysis of the GP ex- high-mannose form.
pressed in Sf9 cells in combination with glycosidase di-
gestion revealed that in addition to the mature GP a ACKNOWLEDGMENTS
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